Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: The SANDS trial

Journal of Clinical Hypertension

Volumn 11, Issue 10, 2009, Pages 540-548

  Weir, Matthew R ^a   Yeh, Fawn ^b   Silverman, Angela ^c   Devereux, Richard B ^d   Galloway, James M ^e   Henderson, Jeffrey A ^f   Howard, William J ^c   Russell, Marie ^g   Wilson, Charlton ^g   Ratner, Robert ^c   Sorkin, John ^a   Umans, Jason G ^c   Fleg, Jerome L ^h   Stylianou, Mario ^h   Lee, Elisa ^b   Howard, Barbara V ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c MEDSTAR RESEARCH INSTITUTE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f Black Hills Center for American Indian Health   (United States)

^g PHOENIX INDIAN MEDICAL CENTER   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN; ATENOLOL; DOXAZOSIN; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LISINOPRIL; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MINOXIDIL; NIFEDIPINE; RENIN; RESERPINE; VALSARTAN;

ACUTE KIDNEY FAILURE; ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRADYCARDIA; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG DOSE TITRATION; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FATIGUE; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; ALGORITHMS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DRUG TOLERANCE; FEMALE; HUMANS; HYPERTENSION; LISINOPRIL; LOSARTAN; MALE; MIDDLE AGED; UNITED STATES;

EID: 70349737857     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00121.x     Document Type: Article

References (16)

1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA. 2003;289:2560-2572.
2. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin survival study (4S). Lancet. 1994;344:1383-1389.
3. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504.
4. Howard BV, Roman M, Devereux R, et al. Effects of lower target for blood pressure and ldl cholesterol on atherosclerosis in diabetes: The SANDS randomized trial. JAMA. 2008;299:1678-1689.
5. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197.
6. Russell M, Fleg JL, Galloway WJ, et al. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes-the Stop Atherosclerosis in Native Diabetics Study (SANDS). Am Heart J. 2006;152:867-875.
7. Black HR. The evolution of low-dose diuretic therapy: The lessons from clinical trials. Am J Med. 1996;101:47S-52S.
8. Neutel JM, Black HR, Weber MA. Combination therapy with diuretics: An evolution of understanding. Am J Med. 1996;101:61S-70S.
9. Palmieri V, Tracy RP, Roman MJ, et al. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: The strong heart study. Diabetes Care. 2003;26:2764-2769.
10. El Assaad MA, Topouchian JA, Darne BM, et al. Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit. 2002;7:237-241.
11. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT study group. Lancet. 1998;351:1755-1762.
12. Whelton PK, Barzilay J, Cushman WC, et al. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165:1401-1409.
13. Jamerson K, Bakris GL, Dahlof B, et al. Exceptional early blood pressure control rates: The ACCOMPLISH trial. Blood Press. 2007;16:80-86.
14. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham heart study. Circulation. 2001;103:1245-1249.
15. Howard BV, Lee ET, Cowan LD, et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The strong heart study. Am J Epidemiol. 1995;142:254-268.
16. Howard BV, Lee ET, Cowan LD, et al. Rising tide of cardiovascular disease in American Indians. The strong heart study. Circulation. 1999;99:2389-2395.